278 related articles for article (PubMed ID: 29569018)
1. Breast cancer survival, survival disparities, and guideline-based treatment.
Hill DA; Friend S; Lomo L; Wiggins C; Barry M; Prossnitz E; Royce M
Breast Cancer Res Treat; 2018 Jul; 170(2):405-414. PubMed ID: 29569018
[TBL] [Abstract][Full Text] [Related]
2. Black and Hispanic women are less likely than white women to receive guideline-concordant endometrial cancer treatment.
Kaspers M; Llamocca E; Quick A; Dholakia J; Salani R; Felix AS
Am J Obstet Gynecol; 2020 Sep; 223(3):398.e1-398.e18. PubMed ID: 32142825
[TBL] [Abstract][Full Text] [Related]
3. Pre-diagnostic breastfeeding, adiposity, and mortality among parous Hispanic and non-Hispanic white women with invasive breast cancer: the Breast Cancer Health Disparities Study.
Connor AE; Visvanathan K; Baumgartner KB; Baumgartner RN; Boone SD; Hines LM; Wolff RK; John EM; Slattery ML
Breast Cancer Res Treat; 2017 Jan; 161(2):321-331. PubMed ID: 27837379
[TBL] [Abstract][Full Text] [Related]
4. Receipt of Guideline-Concordant Care Does Not Explain Breast Cancer Mortality Disparities by Race in Metropolitan Atlanta.
Collin LJ; Yan M; Jiang R; Gogineni K; Subhedar P; Ward KC; Switchenko JM; Lipscomb J; Miller-Kleinhenz J; Torres MA; Lin J; McCullough LE
J Natl Compr Canc Netw; 2021 Aug; 19(11):1242-1251. PubMed ID: 34399407
[TBL] [Abstract][Full Text] [Related]
5. Method of detection and breast cancer survival disparities in Hispanic women.
Hill DA; Nibbe A; Royce ME; Wallace AM; Kang H; Wiggins CL; Rosenberg RD
Cancer Epidemiol Biomarkers Prev; 2010 Oct; 19(10):2453-60. PubMed ID: 20841385
[TBL] [Abstract][Full Text] [Related]
6. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
Chen L; Li CI
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428
[TBL] [Abstract][Full Text] [Related]
7. Patterns of Evidence-Based Care for the Diagnosis, Staging, and First-line Treatment of Breast Cancer by Race-Ethnicity: A SEER-Medicare Study.
Herbach EL; Nash SH; Lizarraga IM; Carnahan RM; Wang K; Ogilvie AC; Curran M; Charlton ME
Cancer Epidemiol Biomarkers Prev; 2023 Oct; 32(10):1312-1322. PubMed ID: 37436422
[TBL] [Abstract][Full Text] [Related]
8. The joint contribution of tumor phenotype and education to breast cancer survival disparity between Hispanic and non-Hispanic white women.
Boone SD; Baumgartner KB; Joste NE; Pinkston CM; Yang D; Baumgartner RN
Cancer Causes Control; 2014 Mar; 25(3):273-82. PubMed ID: 24337810
[TBL] [Abstract][Full Text] [Related]
9. Sociodemographic disparities in advanced ovarian cancer survival and adherence to treatment guidelines.
Bristow RE; Chang J; Ziogas A; Campos B; Chavez LR; Anton-Culver H
Obstet Gynecol; 2015 Apr; 125(4):833-842. PubMed ID: 25751200
[TBL] [Abstract][Full Text] [Related]
10. Disparities in Receiving Guideline-Concordant Treatment for Lung Cancer in the United States.
Blom EF; Ten Haaf K; Arenberg DA; de Koning HJ
Ann Am Thorac Soc; 2020 Feb; 17(2):186-194. PubMed ID: 31672025
[No Abstract] [Full Text] [Related]
11. Racial disparities in treatment and outcomes between non-Hispanic Black and non-Hispanic White women with nonmetastatic inflammatory breast cancer.
Carbajal-Ochoa WH; Johnson D; Alvarez A; Bernal AM; Anampa JD
Breast Cancer Res Treat; 2023 Sep; 201(2):275-287. PubMed ID: 37442877
[TBL] [Abstract][Full Text] [Related]
12. The association of race/ethnicity, insurance status, and socioeconomic factors with breast cancer care.
Freedman RA; Virgo KS; He Y; Pavluck AL; Winer EP; Ward EM; Keating NL
Cancer; 2011 Jan; 117(1):180-9. PubMed ID: 20939011
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the Quality of Adjuvant Endocrine Therapy Delivery for Breast Cancer Care in the United States.
Daly B; Olopade OI; Hou N; Yao K; Winchester DJ; Huo D
JAMA Oncol; 2017 Jul; 3(7):928-935. PubMed ID: 28152150
[TBL] [Abstract][Full Text] [Related]
14. Racial disparities in the treatment of advanced epithelial ovarian cancer.
Howell EA; Egorova N; Hayes MP; Wisnivesky J; Franco R; Bickell N
Obstet Gynecol; 2013 Nov; 122(5):1025-1032. PubMed ID: 24104782
[TBL] [Abstract][Full Text] [Related]
15. Racial and Ethnic Disparities in Oncotype DX Test Receipt in a Statewide Population-Based Study.
Davis BA; Aminawung JA; Abu-Khalaf MM; Evans SB; Su K; Mehta R; Wang SY; Gross CP
J Natl Compr Canc Netw; 2017 Mar; 15(3):346-354. PubMed ID: 28275035
[No Abstract] [Full Text] [Related]
16. Disparities in breast cancer: a multi-institutional comparative analysis focusing on American Hispanics.
Nahleh Z; Otoukesh S; Mirshahidi HR; Nguyen AL; Nagaraj G; Botrus G; Badri N; Diab N; Alvarado A; Sanchez LA; Dwivedi AK
Cancer Med; 2018 Jun; 7(6):2710-2717. PubMed ID: 29733543
[TBL] [Abstract][Full Text] [Related]
17. Comparing treatment and outcomes of ductal carcinoma in situ among women in Missouri by race.
Madubata CC; Liu Y; Goodman MS; Yun S; Yu J; Lian M; Colditz GA
Breast Cancer Res Treat; 2016 Dec; 160(3):563-572. PubMed ID: 27771840
[TBL] [Abstract][Full Text] [Related]
18. Disparities in Breast Cancer Survival by Socioeconomic Status Despite Medicare and Medicaid Insurance.
Silber JH; Rosenbaum PR; Ross RN; Reiter JG; Niknam BA; Hill AS; Bongiorno DM; Shah SA; Hochman LL; Even-Shoshan O; Fox KR
Milbank Q; 2018 Dec; 96(4):706-754. PubMed ID: 30537364
[TBL] [Abstract][Full Text] [Related]
19. Racial and Ethnic Differences in Breast Cancer Survival: Mediating Effect of Tumor Characteristics and Sociodemographic and Treatment Factors.
Warner ET; Tamimi RM; Hughes ME; Ottesen RA; Wong YN; Edge SB; Theriault RL; Blayney DW; Niland JC; Winer EP; Weeks JC; Partridge AH
J Clin Oncol; 2015 Jul; 33(20):2254-61. PubMed ID: 25964252
[TBL] [Abstract][Full Text] [Related]
20. Racial disparities in survival outcomes by breast tumor subtype among African American women in Memphis, Tennessee.
Vidal G; Bursac Z; Miranda-Carboni G; White-Means S; Starlard-Davenport A
Cancer Med; 2017 Jul; 6(7):1776-1786. PubMed ID: 28612435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
